カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアルファ L-イズロニダーゼ市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Alpha L-Iduronidase Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	■ 発行会社/調査会社：GlobalInfoResearch ■ 商品コード：GIR22NO19113 ■ 発行日：2022年11月（※2025年版があります。お問い合わせください。） ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：100 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（注文後2-3日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のアルファ L-イズロニダーゼ市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

アルファ L-イズロニダーゼ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアルファ L-イズロニダーゼの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アルファ L-イズロニダーゼ市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・IDUA、EC 3.2.1.76

用途別セグメントは次のように区分されます。
・腫瘍学、皮膚科、免疫学、筋骨格系疾患

世界のアルファ L-イズロニダーゼ市場の主要な市場プレーヤーは以下のとおりです。
・ArmaGen Inc、BioStrategies LC、Denali Therapeutics Inc、EdiGene Inc、Gain Therapeutics Inc、Immusoft Corp、JCR Pharmaceuticals Co Ltd、Orchard Therapeutics Plc、Ossianix Inc、Rain Bio Inc、RegenxBio Inc、Tega Therapeutics Inc

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アルファ L-イズロニダーゼ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアルファ L-イズロニダーゼメーカーの企業概要、2019年～2022年までのアルファ L-イズロニダーゼの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアルファ L-イズロニダーゼメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アルファ L-イズロニダーゼの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアルファ L-イズロニダーゼの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアルファ L-イズロニダーゼ市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアルファ L-イズロニダーゼの産業チェーンを掲載しています。
・第13、14、15章では、アルファ L-イズロニダーゼの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アルファ L-イズロニダーゼの概要
- 種類別分析（2017年vs2021年vs2028年）：IDUA、EC 3.2.1.76
- 用途別分析（2017年vs2021年vs2028年）：腫瘍学、皮膚科、免疫学、筋骨格系疾患
- 世界のアルファ L-イズロニダーゼ市場規模・予測
- 世界のアルファ L-イズロニダーゼ生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- ArmaGen Inc、BioStrategies LC、Denali Therapeutics Inc、EdiGene Inc、Gain Therapeutics Inc、Immusoft Corp、JCR Pharmaceuticals Co Ltd、Orchard Therapeutics Plc、Ossianix Inc、Rain Bio Inc、RegenxBio Inc、Tega Therapeutics Inc
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：IDUA、EC 3.2.1.76
・用途別分析2017年-2028年：腫瘍学、皮膚科、免疫学、筋骨格系疾患
・アルファ L-イズロニダーゼの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アルファ L-イズロニダーゼのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アルファ L-イズロニダーゼのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アルファ L-イズロニダーゼの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アルファ L-イズロニダーゼの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Alpha L-Iduronidase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Alpha L-Iduronidase market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oncology accounting for % of the Alpha L-Iduronidase global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While IDUA segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Alpha L-Iduronidase include ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, and Gain Therapeutics Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Alpha L-Iduronidase market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IDUA
EC 3.2.1.76
Market segment by Application can be divided into
Oncology
Dermatology
Immunology
Musculoskeletal Disorders
The key market players for global Alpha L-Iduronidase market are listed below:
ArmaGen Inc
BioStrategies LC
Denali Therapeutics Inc
EdiGene Inc
Gain Therapeutics Inc
Immusoft Corp
JCR Pharmaceuticals Co Ltd
Orchard Therapeutics Plc
Ossianix Inc
Rain Bio Inc
RegenxBio Inc
Tega Therapeutics Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alpha L-Iduronidase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alpha L-Iduronidase, with price, sales, revenue and global market share of Alpha L-Iduronidase from 2019 to 2022.
Chapter 3, the Alpha L-Iduronidase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha L-Iduronidase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Alpha L-Iduronidase market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Alpha L-Iduronidase.
Chapter 13, 14, and 15, to describe Alpha L-Iduronidase sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Alpha L-Iduronidase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alpha L-Iduronidase Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 IDUA
1.2.3 EC 3.2.1.76
1.3 Market Analysis by Application
1.3.1 Overview: Global Alpha L-Iduronidase Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Dermatology
1.3.4 Immunology
1.3.5 Musculoskeletal Disorders
1.4 Global Alpha L-Iduronidase Market Size & Forecast
1.4.1 Global Alpha L-Iduronidase Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Alpha L-Iduronidase Sales in Volume (2017-2028)
1.4.3 Global Alpha L-Iduronidase Price (2017-2028)
1.5 Global Alpha L-Iduronidase Production Capacity Analysis
1.5.1 Global Alpha L-Iduronidase Total Production Capacity (2017-2028)
1.5.2 Global Alpha L-Iduronidase Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alpha L-Iduronidase Market Drivers
1.6.2 Alpha L-Iduronidase Market Restraints
1.6.3 Alpha L-Iduronidase Trends Analysis
2 Manufacturers Profiles
2.1 ArmaGen Inc
2.1.1 ArmaGen Inc Details
2.1.2 ArmaGen Inc Major Business
2.1.3 ArmaGen Inc Alpha L-Iduronidase Product and Services
2.1.4 ArmaGen Inc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 BioStrategies LC
2.2.1 BioStrategies LC Details
2.2.2 BioStrategies LC Major Business
2.2.3 BioStrategies LC Alpha L-Iduronidase Product and Services
2.2.4 BioStrategies LC Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Denali Therapeutics Inc
2.3.1 Denali Therapeutics Inc Details
2.3.2 Denali Therapeutics Inc Major Business
2.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Product and Services
2.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 EdiGene Inc
2.4.1 EdiGene Inc Details
2.4.2 EdiGene Inc Major Business
2.4.3 EdiGene Inc Alpha L-Iduronidase Product and Services
2.4.4 EdiGene Inc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Gain Therapeutics Inc
2.5.1 Gain Therapeutics Inc Details
2.5.2 Gain Therapeutics Inc Major Business
2.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Product and Services
2.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Immusoft Corp
2.6.1 Immusoft Corp Details
2.6.2 Immusoft Corp Major Business
2.6.3 Immusoft Corp Alpha L-Iduronidase Product and Services
2.6.4 Immusoft Corp Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 JCR Pharmaceuticals Co Ltd
2.7.1 JCR Pharmaceuticals Co Ltd Details
2.7.2 JCR Pharmaceuticals Co Ltd Major Business
2.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product and Services
2.7.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Orchard Therapeutics Plc
2.8.1 Orchard Therapeutics Plc Details
2.8.2 Orchard Therapeutics Plc Major Business
2.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Product and Services
2.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Ossianix Inc
2.9.1 Ossianix Inc Details
2.9.2 Ossianix Inc Major Business
2.9.3 Ossianix Inc Alpha L-Iduronidase Product and Services
2.9.4 Ossianix Inc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Rain Bio Inc
2.10.1 Rain Bio Inc Details
2.10.2 Rain Bio Inc Major Business
2.10.3 Rain Bio Inc Alpha L-Iduronidase Product and Services
2.10.4 Rain Bio Inc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 RegenxBio Inc
2.11.1 RegenxBio Inc Details
2.11.2 RegenxBio Inc Major Business
2.11.3 RegenxBio Inc Alpha L-Iduronidase Product and Services
2.11.4 RegenxBio Inc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Tega Therapeutics Inc
2.12.1 Tega Therapeutics Inc Details
2.12.2 Tega Therapeutics Inc Major Business
2.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Product and Services
2.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Alpha L-Iduronidase Breakdown Data by Manufacturer
3.1 Global Alpha L-Iduronidase Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Alpha L-Iduronidase Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Alpha L-Iduronidase
3.4 Market Concentration Rate
3.4.1 Top 3 Alpha L-Iduronidase Manufacturer Market Share in 2021
3.4.2 Top 6 Alpha L-Iduronidase Manufacturer Market Share in 2021
3.5 Global Alpha L-Iduronidase Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Alpha L-Iduronidase Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alpha L-Iduronidase Market Size by Region
4.1.1 Global Alpha L-Iduronidase Sales in Volume by Region (2017-2028)
4.1.2 Global Alpha L-Iduronidase Revenue by Region (2017-2028)
4.2 North America Alpha L-Iduronidase Revenue (2017-2028)
4.3 Europe Alpha L-Iduronidase Revenue (2017-2028)
4.4 Asia-Pacific Alpha L-Iduronidase Revenue (2017-2028)
4.5 South America Alpha L-Iduronidase Revenue (2017-2028)
4.6 Middle East and Africa Alpha L-Iduronidase Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Alpha L-Iduronidase Sales in Volume by Type (2017-2028)
5.2 Global Alpha L-Iduronidase Revenue by Type (2017-2028)
5.3 Global Alpha L-Iduronidase Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Alpha L-Iduronidase Sales in Volume by Application (2017-2028)
6.2 Global Alpha L-Iduronidase Revenue by Application (2017-2028)
6.3 Global Alpha L-Iduronidase Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Alpha L-Iduronidase Sales by Type (2017-2028)
7.2 North America Alpha L-Iduronidase Sales by Application (2017-2028)
7.3 North America Alpha L-Iduronidase Market Size by Country
7.3.1 North America Alpha L-Iduronidase Sales in Volume by Country (2017-2028)
7.3.2 North America Alpha L-Iduronidase Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Alpha L-Iduronidase Sales by Type (2017-2028)
8.2 Europe Alpha L-Iduronidase Sales by Application (2017-2028)
8.3 Europe Alpha L-Iduronidase Market Size by Country
8.3.1 Europe Alpha L-Iduronidase Sales in Volume by Country (2017-2028)
8.3.2 Europe Alpha L-Iduronidase Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Alpha L-Iduronidase Sales by Type (2017-2028)
9.2 Asia-Pacific Alpha L-Iduronidase Sales by Application (2017-2028)
9.3 Asia-Pacific Alpha L-Iduronidase Market Size by Region
9.3.1 Asia-Pacific Alpha L-Iduronidase Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Alpha L-Iduronidase Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Alpha L-Iduronidase Sales by Type (2017-2028)
10.2 South America Alpha L-Iduronidase Sales by Application (2017-2028)
10.3 South America Alpha L-Iduronidase Market Size by Country
10.3.1 South America Alpha L-Iduronidase Sales in Volume by Country (2017-2028)
10.3.2 South America Alpha L-Iduronidase Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alpha L-Iduronidase Sales by Type (2017-2028)
11.2 Middle East & Africa Alpha L-Iduronidase Sales by Application (2017-2028)
11.3 Middle East & Africa Alpha L-Iduronidase Market Size by Country
11.3.1 Middle East & Africa Alpha L-Iduronidase Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Alpha L-Iduronidase Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Alpha L-Iduronidase and Key Manufacturers
12.2 Manufacturing Costs Percentage of Alpha L-Iduronidase
12.3 Alpha L-Iduronidase Production Process
12.4 Alpha L-Iduronidase Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Alpha L-Iduronidase Typical Distributors
13.3 Alpha L-Iduronidase Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Alpha L-Iduronidase Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Alpha L-Iduronidase Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ArmaGen Inc Basic Information, Manufacturing Base and Competitors
Table 4. ArmaGen Inc Major Business
Table 5. ArmaGen Inc Alpha L-Iduronidase Product and Services
Table 6. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. BioStrategies LC Basic Information, Manufacturing Base and Competitors
Table 8. BioStrategies LC Major Business
Table 9. BioStrategies LC Alpha L-Iduronidase Product and Services
Table 10. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Denali Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 12. Denali Therapeutics Inc Major Business
Table 13. Denali Therapeutics Inc Alpha L-Iduronidase Product and Services
Table 14. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. EdiGene Inc Basic Information, Manufacturing Base and Competitors
Table 16. EdiGene Inc Major Business
Table 17. EdiGene Inc Alpha L-Iduronidase Product and Services
Table 18. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Gain Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 20. Gain Therapeutics Inc Major Business
Table 21. Gain Therapeutics Inc Alpha L-Iduronidase Product and Services
Table 22. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Immusoft Corp Basic Information, Manufacturing Base and Competitors
Table 24. Immusoft Corp Major Business
Table 25. Immusoft Corp Alpha L-Iduronidase Product and Services
Table 26. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. JCR Pharmaceuticals Co Ltd Basic Information, Manufacturing Base and Competitors
Table 28. JCR Pharmaceuticals Co Ltd Major Business
Table 29. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product and Services
Table 30. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Orchard Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 32. Orchard Therapeutics Plc Major Business
Table 33. Orchard Therapeutics Plc Alpha L-Iduronidase Product and Services
Table 34. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Ossianix Inc Basic Information, Manufacturing Base and Competitors
Table 36. Ossianix Inc Major Business
Table 37. Ossianix Inc Alpha L-Iduronidase Product and Services
Table 38. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Rain Bio Inc Basic Information, Manufacturing Base and Competitors
Table 40. Rain Bio Inc Major Business
Table 41. Rain Bio Inc Alpha L-Iduronidase Product and Services
Table 42. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. RegenxBio Inc Basic Information, Manufacturing Base and Competitors
Table 44. RegenxBio Inc Major Business
Table 45. RegenxBio Inc Alpha L-Iduronidase Product and Services
Table 46. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Tega Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 48. Tega Therapeutics Inc Major Business
Table 49. Tega Therapeutics Inc Alpha L-Iduronidase Product and Services
Table 50. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Alpha L-Iduronidase Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Alpha L-Iduronidase Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Alpha L-Iduronidase, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Alpha L-Iduronidase Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Alpha L-Iduronidase Production Site of Key Manufacturer
Table 56. Alpha L-Iduronidase New Entrant and Capacity Expansion Plans
Table 57. Alpha L-Iduronidase Mergers & Acquisitions in the Past Five Years
Table 58. Global Alpha L-Iduronidase Sales by Region (2017-2022) & (K Units)
Table 59. Global Alpha L-Iduronidase Sales by Region (2023-2028) & (K Units)
Table 60. Global Alpha L-Iduronidase Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Alpha L-Iduronidase Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
Table 63. Global Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
Table 64. Global Alpha L-Iduronidase Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Alpha L-Iduronidase Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Alpha L-Iduronidase Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Alpha L-Iduronidase Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
Table 69. Global Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
Table 70. Global Alpha L-Iduronidase Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Alpha L-Iduronidase Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Alpha L-Iduronidase Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Alpha L-Iduronidase Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Alpha L-Iduronidase Sales by Country (2017-2022) & (K Units)
Table 75. North America Alpha L-Iduronidase Sales by Country (2023-2028) & (K Units)
Table 76. North America Alpha L-Iduronidase Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Alpha L-Iduronidase Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
Table 79. North America Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
Table 80. North America Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
Table 81. North America Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
Table 82. Europe Alpha L-Iduronidase Sales by Country (2017-2022) & (K Units)
Table 83. Europe Alpha L-Iduronidase Sales by Country (2023-2028) & (K Units)
Table 84. Europe Alpha L-Iduronidase Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Alpha L-Iduronidase Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
Table 87. Europe Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
Table 88. Europe Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
Table 89. Europe Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Alpha L-Iduronidase Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Alpha L-Iduronidase Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Alpha L-Iduronidase Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Alpha L-Iduronidase Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
Table 98. South America Alpha L-Iduronidase Sales by Country (2017-2022) & (K Units)
Table 99. South America Alpha L-Iduronidase Sales by Country (2023-2028) & (K Units)
Table 100. South America Alpha L-Iduronidase Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Alpha L-Iduronidase Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
Table 103. South America Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
Table 104. South America Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
Table 105. South America Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Alpha L-Iduronidase Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Alpha L-Iduronidase Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Alpha L-Iduronidase Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Alpha L-Iduronidase Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Alpha L-Iduronidase Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Alpha L-Iduronidase Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Alpha L-Iduronidase Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Alpha L-Iduronidase Sales by Application (2023-2028) & (K Units)
Table 114. Alpha L-Iduronidase Raw Material
Table 115. Key Manufacturers of Alpha L-Iduronidase Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Alpha L-Iduronidase Typical Distributors
Table 119. Alpha L-Iduronidase Typical Customers
List of Figures
Figure 1. Alpha L-Iduronidase Picture
Figure 2. Global Alpha L-Iduronidase Revenue Market Share by Type in 2021
Figure 3. IDUA
Figure 4. EC 3.2.1.76
Figure 5. Global Alpha L-Iduronidase Revenue Market Share by Application in 2021
Figure 6. Oncology
Figure 7. Dermatology
Figure 8. Immunology
Figure 9. Musculoskeletal Disorders
Figure 10. Global Alpha L-Iduronidase Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Alpha L-Iduronidase Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Alpha L-Iduronidase Sales (2017-2028) & (K Units)
Figure 13. Global Alpha L-Iduronidase Price (2017-2028) & (US$/Unit)
Figure 14. Global Alpha L-Iduronidase Production Capacity (2017-2028) & (K Units)
Figure 15. Global Alpha L-Iduronidase Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Alpha L-Iduronidase Market Drivers
Figure 17. Alpha L-Iduronidase Market Restraints
Figure 18. Alpha L-Iduronidase Market Trends
Figure 19. Global Alpha L-Iduronidase Sales Market Share by Manufacturer in 2021
Figure 20. Global Alpha L-Iduronidase Revenue Market Share by Manufacturer in 2021
Figure 21. Alpha L-Iduronidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Alpha L-Iduronidase Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Alpha L-Iduronidase Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Alpha L-Iduronidase Sales Market Share by Region (2017-2028)
Figure 25. Global Alpha L-Iduronidase Revenue Market Share by Region (2017-2028)
Figure 26. North America Alpha L-Iduronidase Revenue (2017-2028) & (USD Million)
Figure 27. Europe Alpha L-Iduronidase Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Alpha L-Iduronidase Revenue (2017-2028) & (USD Million)
Figure 29. South America Alpha L-Iduronidase Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Alpha L-Iduronidase Revenue (2017-2028) & (USD Million)
Figure 31. Global Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
Figure 32. Global Alpha L-Iduronidase Revenue Market Share by Type (2017-2028)
Figure 33. Global Alpha L-Iduronidase Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
Figure 35. Global Alpha L-Iduronidase Revenue Market Share by Application (2017-2028)
Figure 36. Global Alpha L-Iduronidase Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
Figure 38. North America Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
Figure 39. North America Alpha L-Iduronidase Sales Market Share by Country (2017-2028)
Figure 40. North America Alpha L-Iduronidase Revenue Market Share by Country (2017-2028)
Figure 41. United States Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
Figure 45. Europe Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
Figure 46. Europe Alpha L-Iduronidase Sales Market Share by Country (2017-2028)
Figure 47. Europe Alpha L-Iduronidase Revenue Market Share by Country (2017-2028)
Figure 48. Germany Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Alpha L-Iduronidase Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Alpha L-Iduronidase Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Alpha L-Iduronidase Revenue Market Share by Region (2017-2028)
Figure 57. China Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
Figure 64. South America Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
Figure 65. South America Alpha L-Iduronidase Sales Market Share by Country (2017-2028)
Figure 66. South America Alpha L-Iduronidase Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Alpha L-Iduronidase Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Alpha L-Iduronidase Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Alpha L-Iduronidase in 2021
Figure 78. Manufacturing Process Analysis of Alpha L-Iduronidase
Figure 79. Alpha L-Iduronidase Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

世界のアルファ L-イズロニダーゼ市場2022年：市場規模予測（～2028年）

グローバル市場調査会社